IFAPP Academy is pleased to welcome the new members of its Editorial Board (EB), whose purpose is to provide strategic guidance and support the Academy External Communications initiatives aimed at informing, educating, and eliciting discussion in the field of medicines development.
The EB will be working in close collaboration with IFAPP Academy’s Medical Editor, Digital Communications Manager, and Operations Team in developing a strategic communications framework (Newsletter, “Conversations…” webinars, interviews, etc.) and its frequency to the target audience.
Thanks in advance to the following members of the Editorial Board for their expert contribution to IFAPP Academy:
Roberto Araujo, MD, Ph.D., Global Medical Learning and Capability Lead, Sanofi
Jamsheed Banaji, Medical Excellence Lead, Hospital Business Unit, Pfizer
Domenico Criscuolo, MD, Ph.D., Past President, Italian Association of Pharmaceutical Medicine
Pravin Chopra, MD, Former Head of Medical Affairs, Sanofi and Pfizer
Soneil Guptha, MD FACC, Independent Consultant in Pharmaceutical Medicine,
Nishtha Khatri, MD, Seth GS Medical College, and KEM Hospital, Mumbai, India
Luis Laranjeira, MD, MBA, Medical Director, Eli Lilly, Portugal
Xiaojing Li, Senior Medical Manager, CSPC Pharma Ltd., China
Joao Massud-Filho, MD, Senior Consultant on Drug Development; Sao Paolo, Brazil
IFAPP Academy provides an online, continuing professional development course, Medical Affairs in Medicines Development, resulting in the Professional Certification, Certified Medicines Development (CMD).